U.S. House health panel advances 15 bills on drug control and price transparency

Traders Union
All News
Financial News
House panel health bills

Highlights

U.S. House Energy and Commerce Subcommittee on Health advances 15 bills addressing healthcare costs, price transparency, and illicit drug threats during markup on June 12, 2024.
The legislative package includes the Lower Costs, More Transparency Act of 2026, Premium Transparency Act, and bills targeting drug threats like the Combatting Illicit Xylazine Act and STOP Nitazenes Act.
Chairman Morgan Griffith emphasizes bipartisan support for measures expanding Medicare Advantage transparency, community health center access, and consumer information to improve healthcare affordability.

Subcommittee action on healthcare costs and drug threats

As reported by the House Committee on Energy and Commerce, the Subcommittee on Health advances 15 bills to the full committee during a markup led by Chairman Morgan Griffith of Virginia. Griffith says the package is meant to lower healthcare costs, improve price transparency and protect communities from the harms of illicit substances.

Among the measures forwarded by voice vote are the Lower Costs, More Transparency Act of 2026, the Premium Transparency Act, the Prior Authorization Accountability Act, the Prices on the Wall Act of 2026, and the Medicare Advantage Cost Transparency Act. The panel also advances legislation to expand data transparency for supplemental benefits under Medicare Advantage, with that bill moving as amended by voice vote.

On drug policy, the subcommittee sends forward the Combatting Illicit Xylazine Act, Tyler's Law, the STOP Nitazenes Act, the ALERT Communities Act and the HERO Act. Other healthcare access measures include the Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026, the Expanding Community Access to Health Services Act and the Improving Seniors' Timely Access to Care Act of 2025.

Policy focus on transparency and community care

Griffith says lawmakers still need to refine several of the bills before full committee markup, but he describes the effort as an area with bipartisan importance. He argues that limited transparency leaves patients unable to make informed decisions and keeps pressure on healthcare affordability.

Lawmakers backing individual measures frame the package around both consumer information and frontline care needs. Representative Diana Harshbarger says community health centers often serve as the main access point for primary care in rural and underserved areas, while her bill supports evidence-based nutrition counseling, provider training and team-based care.

Representative Gus Bilirakis says traffickers increasingly use xylazine as a low-cost cutting agent with fentanyl and other illicit drugs, making mixtures more dangerous and harder to treat. Representative Mariannette Miller-Meeks says clearer and more visible pricing information can strengthen competition, help families compare care options and improve accountability across the healthcare system.

Our earlier report on a Joint Economic Committee hearing examined how fraud, weak oversight, and misaligned payment incentives can drive higher spending in Medicare Advantage and Medicaid. The article highlighted expert testimony that while AI and analytics may improve detection of irregular payments, deeper structural reforms, better data sharing, and stronger safeguards are needed to reduce waste and protect taxpayer funds.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.